SGLT2 inhibitor requires co-administration with diuretics to effectively reduce interstitial fluid retention: the DAPA-BODY trial. - Masuda T; Asakura-Kinoshita M; Oka K; Ohara K; Sakai M; Miura M; Misawa K; Hirai K; Morinari M; Akimoto T; Shimada K; Nagata D; et al. (Hypertension research : official journal of the Japanese Society of Hypertension, 2026)